Compare USCB & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | USCB | CGC |
|---|---|---|
| Founded | 2002 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Pharmaceuticals and Biotechnology |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 335.0M | 401.0M |
| IPO Year | 2021 | 2023 |
| Metric | USCB | CGC |
|---|---|---|
| Price | $20.90 | $1.00 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $23.00 | N/A |
| AVG Volume (30 Days) | 59.0K | ★ 6.4M |
| Earning Date | 04-23-2026 | 05-29-2026 |
| Dividend Yield | ★ 2.72% | N/A |
| EPS Growth | 7.26 | ★ 84.17 |
| EPS | ★ 0.51 | N/A |
| Revenue | N/A | ★ $12,759,000.00 |
| Revenue This Year | $26.46 | $8.27 |
| Revenue Next Year | $9.67 | $15.68 |
| P/E Ratio | $40.98 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.06 | $0.84 |
| 52 Week High | $20.93 | $2.38 |
| Indicator | USCB | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 71.56 | 51.08 |
| Support Level | $17.83 | $0.99 |
| Resistance Level | N/A | $1.13 |
| Average True Range (ATR) | 0.58 | 0.05 |
| MACD | 0.14 | 0.01 |
| Stochastic Oscillator | 98.53 | 59.43 |
USCB Financial Holdings Inc is a bank holding company. Through its banking subsidiary, it offers relationship-based banking products, services, and solutions to a diverse set of clients in the local markets it operates in and international clients with U.S. banking needs. The Group's products and services offerings mainly include traditional deposit products, including commercial and consumer checking accounts, money market deposit accounts, savings accounts, etc.; e-banking services; title insurance policies for real estate transactions; and a variety of lending products such as small business loans, commercial real estate loans, business credit cards, etc.; and others. Geographically, its primary banking market is South Florida.
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.